AdvertisementSynnovation Therapeutics launched this week with $102 million in financing led by Third Rock Ventures with participation from Nextech, Lilly Asia Ventures, Sirona Capital, and Cormorant Asset Management. Former research … Continue reading Cancer drug start-up launched by former Incyte researchers gets $102 million in funding